The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Performance was driven by disciplined cost management and accelerating synergy capture, which offset a modestly challenging volume environment where comparable volumes declined 1.5%.

Management attributes the 6% adjusted EPS growth to the successful integration of Berry, specifically citing the ability to maintain dollar earnings through responsible pricing actions despite input cost inflation.

The core portfolio, representing 50% of sales, outperformed the total company with flat volumes in focus categories and stronger EBIT margins of 12.3% due to favorable product mix.

Operational resilience was tested by U.S. winter storms in January and February, resulting in a $25 million unfavorable impact due to lost production days in the Midwest and Northeast.

Portfolio sharpening progressed with 6 divestiture agreements reached for noncore businesses, totaling $500 million in annual revenue, to focus on higher-growth opportunities.

Management emphasized that their global supply network and minimal reliance on Middle Eastern resin (less than 5% of sourcing) provide a competitive advantage in maintaining supply continuity.

Fiscal 2026 adjusted EPS guidance of $3.98 to $4.03 assumes a 20% year-over-year growth in Q4, primarily driven by the full-period contribution of the Berry acquisition.

Free cash flow guidance was lowered to $1.5 billion - $1.6 billion (from $1.8 billion - $1.9 billion) due to a strategic decision to hold higher inventory levels to ensure customer supply during Middle East volatility.

Management expects to exceed initial Year 1 synergy targets, raising the goal to $270 million from $260 million, with a clear path to $650 million cumulatively over three years.

The company will transition to a December 31 fiscal year-end starting in 2027 to enhance peer comparability and simplify investor modeling.

Leverage is expected to end the year at 3.4x to 3.5x, with a committed pathway back to the 2.5x to 3.0x target range as supply chains normalize and divestiture proceeds are applied to debt.

Divestiture of 6 noncore businesses at an average multiple of 6x will generate approximately $500 million in cash proceeds for debt reduction.

The company is consolidating select corporate functions to a new U.S. headquarters in Miami, Florida, starting in 2027 to align with its operating footprint.

Middle East conflict is identified as a primary driver of recent resin inflation, though management expects no material impact on Q4 earnings due to pass-through mechanisms.

A $25 million headwind from Q3 winter storms is viewed as a non-recurring operational disruption that impacted the Rigid Packaging segment specifically.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Management explained that 70% of the business is contracted with pass-through clauses, while the 30% non-contracted portion is managed through general price increases.

They are engaging in collaborative, non-mechanical discussions with contracted customers to seek relief for inflation that falls outside 'business-as-usual' parameters.

The $300 million cash flow impact is primarily a timing issue; management expects this to reverse and normalize as supply chain volatility subsides.

Inventory levels are being maintained volumetrically, but the cash impact is magnified by the higher cost of the resin being held.

While Q4 is assumed to mirror Q3's 1.5% decline, management noted that April volumes actually looked better than that baseline.

Management observes that consumers remain stretched and value-seeking, but large customers are showing a continued commitment to supporting volumes through promotional activity.

Healthcare volumes were slightly down due to a weak cold and flu season and U.S. storm disruptions, but the segment maintained positive mix.

Management remains bullish on the category, citing new partnerships in GLP-1 drug packaging and a new coating facility in Malaysia as future drivers.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.